Percorsi clinici
Febbre di origine sconosciuta (FUO): approccio diagnostico attraverso un caso clinico
Fever of unknown origin: Diagnostic approach through a clinical case
Davide Ursi, Simona Puzone, Caterina Strisciuglio
Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università della Campania “Luigi Vanvitelli”
Ottobre 2020 - pagg. 519 -525 | DOI: 10.53126/MEB39519
Abstract
The paper reports the case of a 12-year-old female affected by ulcerative colitis and treated with double immunosuppressant therapy (methotrexate and infliximab). The patient presented with 7 day-lasting fever associated with pharyngotonsillar hyperaemia, cheilitis, vesicular-bollous lesions on labial mucosa and rash on malar regions, chest and upper extremities. Since full blood count showed lymphocytosis and inflammatory markers were negative, a viral infection was suspected. Virological tests identified the presence of IgM against Cytomegalovirus (CMV), Herpes and Mumps viruses, but Real-Time PCR was negative for the DNA detection of any of those viruses. Despite hospital admission and different investigations, fever persisted for more than 7 days without any explanation. Therefore, it was considered as Fever of unknown origin (FUO). FUO is often an unusual manifestation of a common disease but so far there is not a single validated diagnostic protocol. In the presented case only did the repetition of the Real-Time PCR test after a few days enable CMV DNA to be identified in the patient’s blood and urine and CMV infection to be diagnosed.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis - An evidence-based consensus guideline from the european Crohn’s and colitis organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67(2):292-310.
2. Nahar S, Hokama A, Fujuta J. Clinical significance of cytomegalovirus and other herpes virus infections in ulcerative colitis. Pol Arch Intern Med 2019;129(9):620-6.
3. Benelli E, Carbogno S, Carucci NS, et al. Kawasaki facile e difficile. Medico e Bambino 2017;36(3):155.
4. Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC. Nelson Textbook of Pediatrics, Elsevier 2015.
5. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31(2):390-2.
6. Mirza M, Mirza M, Murugesan V, Olano A. Pericardial effusion due to infliximab therapy for ulcerative colitis. Case reports in gastrointestinal medicine, 2018.
7. Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clinical Infectious Diseases 2012;54 (12):1793-7.
8. Antoon JW, Potisek NM, Lohr JA. Pediatric fever of unknown origin. Pediatrics in review 2015;36(9):380.
9. Antoon JW, Peritz DC, Parsons MR, Skinner AC, Lohr JA. Etiology and resource use of fever of unknown origin in hospitalized children. Hospital pediatrics 2018;8(3):135-40.
10. Chow A, Robinson JL. Fever of unknown origin in children: a systematic review. World Journal of Pediatrics 2011;7(1):5-10.
11. Tolan Jr RW. Fever of unknown origin: a diagnostic approach to this vexing problem. Clinical pediatrics 2010;49(3):207-13.
12. National Collaborating Centre forWomen’s and Children’s Health. Feverish Illness in Children: Assessment and Initial Management in Children Younger than 5 Years; National Collaborating Centre for Women’s and Children’s Health: London, UK, 2013
13. Pasic S, Minic A, Djuric P, et al. Fever of unknown origin in 185 paediatric patients: a single-Centre experience. Acta Pædiatrica 2006;95(4):463-6.
14. Parambir DS, Siegel CA. The risk of malignancy associated with the use of biological agents in patients with inflammatory bowel disease. Gastroenterology Clinics 2014;43(3): 525-41.
15. Dioverti MV, Razonable RR. Cytomegalovirus. Microbiology spectrum 2016;4(4).
16. Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infectious Disorders Drug Targets, 2011;11(5):466-74.
Corrispondenza: ursi.davide@gmail.com